RESUMEN
Herein, we report the synthesis of a metal-organic layer, Hf-Ru-Au, containing Ru(bipyridine)32+-type photosensitizers and (phosphine)-AuCl catalysts for photoredox Au-catalyzed cross-coupling of allenoates, alkenes, or alkynes with aryldiazonium salts to afford furanone, tetrahydrofuran, or aryl alkyne derivatives, respectively. Site isolation of (phosphine)-AuCl complexes in Hf-Ru-Au prevents Au catalyst deactivation via ligand redistribution, Au(I) disproportionation, and aryl-phosphine reductive elimination, while the proximity between the Ru photosensitizers and Au catalysts enhances catalytic efficiency, with 14-200 times higher activity over those of the homogeneous controls in the cross-coupling reactions.
Asunto(s)
Oro , Fármacos Fotosensibilizantes , Alquenos , Alquinos , CatálisisRESUMEN
Herein we report that dimensional reduction from three-dimensional nanoscale metal-organic frameworks (nMOFs) to two-dimensional nanoscale metal-organic layers (nMOLs) increases the frequency of encounters between photosensitizers and oxygen and facilitates the diffusion of singlet oxygen from the nMOL to significantly enhance photodynamic therapy. The nMOFs and nMOLs share the same M12-oxo (M = Zr, Hf) secondary building units and 5,15-di-p-benzoatoporphyrin (DBP) ligands but exhibit three-dimensional and two-dimensional topologies, respectively. Molecular dynamics simulations and experimental studies revealed that the nMOLs with a monolayer morphology enhanced the generation of reactive oxygen species and exhibited over an order of magnitude higher cytotoxicity over the nMOFs. In a mouse model of triple-negative breast cancer, Hf-DBP nMOL showed 49.1% more tumor inhibition, an 80% higher cure rate, and 16.3-fold lower metastasis potential than Hf-DBP nMOF.
Asunto(s)
Estructuras Metalorgánicas , Nanoestructuras , Neoplasias , Fotoquimioterapia , Animales , Estructuras Metalorgánicas/farmacología , Estructuras Metalorgánicas/uso terapéutico , Ratones , Neoplasias/patología , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/uso terapéutico , Oxígeno Singlete/uso terapéuticoRESUMEN
Intermolecular photoredox ene-carbonyl reductive coupling reactions typically have low product selectivity owing to competing dimerization and/or reduction of ketyl radicals. Herein, we report a metal-organic layer (MOL), Hf-Ir-OTf, as a bifunctional photocatalyst for selective photoredox reductive coupling of ketones or aldehydes with electron-deficient alkenes. Composed of iridium-based photosensitizers (Ir-PSs) and triflated Hf12 clusters, Hf-Ir-OTf uses Lewis acidic Hf sites to bind and activate electron-deficient alkenes to accept ketyl radicals generated by adjacent Ir-PSs, thereby suppressing undesired dimerization and reduction of ketyl radicals to enhance the selectivity for the cross-coupling products. The MOL-catalyzed reductive coupling reaction accommodates a variety of olefinic substrates and tolerates reducible groups, nicely complementing current methods for cross-coupling reactions.
RESUMEN
We report the design of a bifunctional metal-organic layer (MOL), Hf12 -Ru-Co, composed of [Ru(DBB)(bpy)2 ]2+ [DBB-Ru, DBB=4,4'-di(4-benzoato)-2,2'-bipyridine; bpy=2,2'-bipyridine] connecting ligand as a photosensitizer and Co(dmgH)2 (PPA)Cl (PPA-Co, dmgH=dimethylglyoxime; PPA=4-pyridinepropionic acid) on the Hf12 secondary building unit (SBU) as a hydrogen-transfer catalyst. Hf12 -Ru-Co efficiently catalyzed acceptorless dehydrogenation of indolines and tetrahydroquinolines to afford indoles and quinolones. We extended this strategy to prepare Hf12 -Ru-Co-OTf MOL with a [Ru(DBB)(bpy)2 ]2+ photosensitizer and Hf12 SBU capped with triflate as strong Lewis acids and PPA-Co as a hydrogen transfer catalyst. With three synergistic active sites, Hf12 -Ru-Co-OTf competently catalyzed dehydrogenative tandem transformations of indolines with alkenes or aldehydes to afford 3-alkylindoles and bisindolylmethanes with turnover numbers of up to 500 and 460, respectively, illustrating the potential use of MOLs in constructing novel multifunctional heterogeneous catalysts.
RESUMEN
We report the design of a new multifunctional metal-organic layer (MOL), Hf12-Ir-OTf, comprising triflate (OTf)-capped Hf12 secondary building units (SBUs) and photosensitizing Ir(DBB)[dF(CF3)ppy]2+ [DBB-Ir-F, DBB = 4,4'-di(4-benzoato)-2,2'-bipyridine; dF(CF3)ppy = 2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine] bridging ligands. Hf12-Ir-OTf effectively catalyzed dehydrogenative cross-couplings of heteroarenes with ethers, amines, and unactivated alkanes with turnover numbers of 930, 790, and 950, respectively. Hf12-Ir-OTf also competently catalyzed late-stage functionalization of bioactive and drug molecules such as caffeine, Fasudil, and Metyrapone. The superior catalytic performance of Hf12-Ir-OTf over a mixture of photoredox catalyst and stoichiometric amounts of Brønsted acids or substoichiometric amounts (20 mol %) of Lewis acids is attributed to the close proximity (1.2 nm) between photoredox and Lewis acid catalysts in Hf12-Ir-OTf, which not only facilitates the reaction between the carbon radical and the activated heteroarene but also accelerates the electron transfer from the nitrogen radical intermediate to the Ir(IV) species in the catalytic cycle.
RESUMEN
As a monolayered version of nanoscale metal-organic frameworks (nMOFs), nanoscale metal-organic layers (nMOLs) represent an emerging class of highly tunable two-dimensional materials for hierarchical functionalization and with facile access to analytes. Here we report the design of the first nMOL-based biosensor for ratiometric pH and oxygen sensing in mitochondria. Cationic Hf12-Ru nMOL was solvothermally synthesized by laterally connecting Hf12 secondary building units (SBUs) with oxygen-sensitive Ru(bpy)32+-derived DBB-Ru ligands (bpy = 2,2'-bipyridine). The Hf12-Ru nMOL was then covalently functionalized with pH-sensitive fluorescein isothiocyanate and pH/oxygen-independent Rhodamine-B isothiocyanate through thiourea linkages to afford Hf12-Ru-F/R as a mitochondria-targeted ratiometric sensor for pH and O2 in live cells. High-resolution confocal microscope imaging with Hf12-Ru-F/R revealed a positive correlation between pH and local O2 concentration in mitochondria. Our work shows the potential of nMOL-based ratiometric biosensors in sensing and imaging of biologically important analytes in live cells.
Asunto(s)
Técnicas Biosensibles/métodos , Estructuras Metalorgánicas/química , Nanoestructuras/química , Oxígeno/análisis , Línea Celular , Humanos , Concentración de Iones de Hidrógeno , Mitocondrias/química , Nanoestructuras/ultraestructuraRESUMEN
Metal-organic layers (MOLs) have recently emerged as a novel class of molecular two-dimensional (2D) materials with significant potential for catalytic applications. Herein we report the design of a new multifunctional MOL, Hf12-Ir-Ni, by laterally linking Hf12 secondary building units (SBUs) with photosensitizing Ir(DBB)[dF(CF3)ppy]2+ [DBB-Ir-F, DBB = 4,4'-di(4-benzoato)-2,2'-bipyridine; dF(CF3)ppy = 2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine] bridging ligands and vertically terminating the SBUs with catalytic Ni(MBA)Cl2 [MBA = 2-(4'-methyl-[2,2'-bipyridin]-4-yl)acetate] capping agents. Hf12-Ir-Ni was synthesized in a bottom-up approach and characterized by TEM, AFM, PXRD, TGA, NMR, ICP-MS, UV-vis, and luminescence spectroscopy. The proximity between photosensitizing Ir centers and catalytic Ni centers (â¼0.85 nm) in Hf12-Ir-Ni facilitates single electron transfer, leading to a 15-fold increase in photoredox reactivity. Hf12-Ir-Ni was highly effective in catalytic C-S, C-O, and C-C cross-coupling reactions with broad substrate scopes and turnover numbers of â¼4500, â¼1900, and â¼450, respectively.
RESUMEN
With tunability and porosity, nanoscale metal-organic frameworks (nMOFs) can incorporate multiple components to realize complex functions for biomedical applications. Here we report the synthesis of W18@Hf12-DBB-Ir, a new nMOF assembly hierarchically incorporating three high-Z components-Hf-based metal-oxo clusters, Ir-based bridging ligands, and W-based polyoxometalates (POMs)-as a multifarious radioenhancer. Cationic Hf12-DBB-Ir was built from Hf12 secondary building units (SBUs) and [Ir(bpy)2(ppy)]+ (bpy = 2,2'-bipyridine, ppy = 2-phenylpyridine) derived dicarboxylate ligands (DBB-Ir) and then loaded with Wells-Dawson-type [P2W18O62]6- (W18) POMs to afford W18@Hf12-DBB-Ir. Upon X-ray irradiation, W18@Hf12-DBB-Ir significantly enhances hydroxyl radical generation from Hf12 SBUs, singlet oxygen generation from DBB-Ir ligands, and superoxide generation from W18 POMs, respectively. Through synergistic cell killing by these distinct reactive oxygen species, W18@Hf12-DBB-Ir elicited superb anticancer efficacy with >98% tumor regression at a low X-ray dose of 5 × 1 Gy.
Asunto(s)
Antineoplásicos/uso terapéutico , Estructuras Metalorgánicas/uso terapéutico , Nanoestructuras/uso terapéutico , Neoplasias/tratamiento farmacológico , Fármacos Sensibilizantes a Radiaciones/uso terapéutico , Animales , Antineoplásicos/química , Antineoplásicos/efectos de la radiación , Línea Celular Tumoral , Radical Hidroxilo/metabolismo , Estructuras Metalorgánicas/química , Estructuras Metalorgánicas/efectos de la radiación , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Nanoestructuras/química , Nanoestructuras/efectos de la radiación , Fotoquimioterapia , Fármacos Sensibilizantes a Radiaciones/química , Fármacos Sensibilizantes a Radiaciones/efectos de la radiación , Oxígeno Singlete/metabolismo , Rayos XRESUMEN
OBJECTIVES: The aim of this research was to synthesize radiolabeled peptidomimetic integrin alpha(v)beta(3) antagonist with (99m)Tc for rapid targeting of integrin alpha(v)beta(3) receptors in tumor to produce a high tumor to background ratio. METHODS: The amino terminus of 4-[2-(3,4,5,6-tetra-hydropyrimidin-2-ylamino)-ethyloxy]benzoyl-2-(S)-[N-(3-amino-neopenta-1-carbamyl)]-aminoethylsulfonyl-amino-beta-alanine hydrochloride (IAC) was conjugated with N-hydroxysuccinimide ester of HYNIC and labeled with (99m)Tc using tricine with either 1,5-pyridinedicarboxylic acid (PDA) or ethylenediamine-N,N'-diacetic acid (EDDA) as the co-ligand. The products, (99m)Tc EDDA(2)/HYNIC-IAC (P1) and (99m)Tc PDA (tricin)/HYNIC-IAC (P2) were subjected to in vitro serum stability, receptor-binding, biodistribution and imaging studies. RESULTS: P1 and P2 were synthesized with an overall yield of >80%. P1 was slightly more stable than P2 when incubated in serum at 37 degrees C for 18 hrs (84 vs 77% intact). The In vitro receptor-binding of P1 was higher than that of P2 (78.02 +/- 13.48 vs 51.05 +/- 14.05%) when incubated with alpha(v)beta(3) at a molar excess (0.8 muM). This receptor binding was completely blocked by a molar excess of an unlabeled peptidomimetic antagonist. Their differences shown in serum stability and the receptor-binding appeared to be related to their biological behaviors in tumor uptake and retention; the 1 h tumor uptakes of P1 and P2 were 3.17+/-0.52 and 2.13+/-0.17 % ID/g, respectively. P1 was retained in the tumor longer than P2. P1 was excreted primarily through the renal system whereas P2 complex was excreted equally via both renal and hepatobiliary systems. Thus, P1 was retained in the whole-body with 27.25 +/- 3.67% ID at 4 h whereas 54.04 +/- 3.57% ID of P2 remained in the whole-body at 4 h. This higher whole-body retention of P2 appeared to be resulted from a higher amount of radioactivity retained in liver and intestine. These findings were supported by imaging studies showing higher tumor-to-abdominal contrast for P1 than for P2 at 3 h postinjection. CONCLUSIONS: P1 showed good tumor targeting properties with a rapid tumor uptake, prolonged tumor retention and fast whole-body clearance kinetics. These findings warrant further investigation of the HYNIC method of (99m)Tc labeling of other peptidomimetic antagonists using EDDA as a coligand.